Abbott Laboratories's operating margin was 18.2% for fiscal year 2025 (the twelve months to 31 Dec 2025), up 1.9 points from fiscal 2024.
In the third quarter of fiscal 2026 (the three months to 30 Sep 2026) it was 10.4%, down 7.7 points from a year earlier.
From Abbott Laboratories's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 4 Nov 2026.
Fiscal 2025
18.2%
+1.9 pts
Q3 FY2026
10.4%
−7.7 pts on a year
Average over 10 years
15.1%
FY 2016–FY 2025
Operating margin by fiscal year
Change in points on the year before, under each year. From FY 2016 to FY 2025, Abbott Laboratories's operating margin went from 14.5% to 18.2%; the highest was 19.6% in FY 2021.
Abbott Laboratories operating margin, fiscal years
Period
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Operating margin
14.5%
5.7%
11.9%
14.2%
15.5%
19.6%
19.2%
16.2%
16.3%
18.2%
Period end
31 Dec 2016
31 Dec 2017
31 Dec 2018
31 Dec 2019
31 Dec 2020
31 Dec 2021
31 Dec 2022
31 Dec 2023
31 Dec 2024
31 Dec 2025
Operating margin by quarter
The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.
Operating margin is operating income divided by revenue. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.
Abbott Laboratories's other figures
Operating margin of comparable companies
Everything on ABT, in the terminal.
Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.